Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry

References

• Brosens LA, Offerhaus GJ, Giardiello FM. Hereditary colorectal cancer: genetics and screening. 2015. Surg Clin North Am. 95:1067–1080. DOI:10.1016/j.suc.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. DOI:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Lynch JP, Hoops TC. The genetic pathogenesis of colorectal cancer. Hematol Oncol Clin N Am. 2002;16(4):775–810. DOI:10.1016/S0889-8588(02)00029-1.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Issa JP. 2004. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev. 23(1–2):29–39.
   PubMed Web of Science ®Google Scholar
• Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colorectal cancer. Cell. 87(2):159–170.
   PubMed Web of Science ®Google Scholar
• Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW. APC mutations occur early during colorectal tumorigenesis. Nature. 1992;359(6392):235–237. DOI:10.1038/359235a0.
   PubMed Web of Science ®Google Scholar
• Fernández-Bañares FEM, Navarro E, Cabré E, Boix J, Abad-Lacruz A, Klaassen J, Planas R, Humbert P, Pastor C. 1996. Changes of the mucosal n-3 and n-6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut. 38(2):254–259.
   PubMed Web of Science ®Google Scholar
• Abir F, Alva S, Kaminski DL, Longo WE. The role of arachidonic acid regulatory enzymes in colorectal disease. Dis Colon Rectum. 2005;48(7):1471–1483. DOI:10.1007/s10350-005-0015-y.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr. 2004;79(6):935–945. DOI:10.1093/ajcn/79.6.935.
   PubMed Web of Science ®Google Scholar
• Yoshie T, Nishiumi S, Izumi Y, Sakai A, Inoue J, Azuma T, Yoshida M. Regulation of the metabolite profile by an APC gene mutation in colorectal cancer. Cancer Sci. 2012;103(6):1010–1021. DOI:10.1111/j.1349-7006.2012.02262.x.
   PubMed Web of Science ®Google Scholar
• Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol. 2007;25(19):2840–2846. DOI:10.1200/JCO.2006.09.7550.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29(11):1181–1189. DOI:10.1080/004982599238047.
   PubMed Web of Science ®Google Scholar
• Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M. Metabolite profiling of human colon carcinoma–deregulation of TCA cycle and amino acid turnover. 2008. Mol Cancer. 7:72. DOI:10.1186/1476-4598-7-72.
   PubMed Web of Science ®Google Scholar
• Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC. Metabolic profiling of human colorectal cancer using High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance (HR-MAS NMR) Spectroscopy and Gas Chromatography Mass Spectrometry (GC/MS). J Proteome Res. 2009;8(1):352–361. DOI:10.1021/pr8006232.
   PubMed Web of Science ®Google Scholar
• Leichtle AB, Nuoffer JM, Ceglarek U, Kase J, Conrad T, Witzigmann H, Thiery J, Fiedler GM. Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics. 2012;8(4):643–653. DOI:10.1007/s11306-011-0357-5.
   PubMed Web of Science ®Google Scholar
• Zhu J, Djukovic D, Deng L, Gu H, Himmati F, Chiorean EG, Raftery D. Colorectal cancer detection using targeted serum metabolic profiling. 2014. J Proteome Res. 13:4120–4130. DOI:10.1021/pr500494u.
   PubMed Web of Science ®Google Scholar
• Bertini I, Cacciatore S, Jensen BV, Schou JV, Johansen JS, Kruhoffer M, Luchinat C, Nielsen DL, Turano P. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res. 2012;72(1):356–364. DOI:10.1158/0008-5472.CAN-11-1543.
   PubMed Web of Science ®Google Scholar
• Jones R, Adel-Alvarez LA, Alvarez OR, Broaddus R, Das S. 2003. Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem. 253(1–2):141–149.
   PubMed Web of Science ®Google Scholar
• Habbel P, Weylandt KH, Lichopoj K, Nowak J, Purschke M, Wang JD, He CW, Baumgart DC, Kang JX. 2009. Docosahexaenoic acid suppresses arachidonic acid-induced proliferation of LS-174T human colon carcinoma cells. World J Gastroenterol. 15(9):1079–1084.
   PubMed Web of Science ®Google Scholar
• Almendingen K, Hostmark AT, Fausa O, Mosdol A, Aabakken L, Vatn MH. Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids. 2007. Int J Cancer. 120:632–637. DOI:10.1002/ijc.22337.
   PubMed Web of Science ®Google Scholar
• Ghadimi R, Kuriki K, Tsuge S, Takeda E, Imaeda N, Suzuki S, Sawai A, Takekuma K, Hosono A, Tokudome Y, et al. 2008. Serum concentrations of fatty acids and colorectal adenoma risk: a case-control study in Japan. Asian Pac J Cancer Prev. 9(1):111–118.
   PubMedGoogle Scholar
• Kojima M, Wakai K, Tokudome S, Suzuki K, Tamakoshi K, Watanabe Y, Kawado M, Hashimoto S, Hayakawa N, Ozasa K. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study. Am J Epidemiol. 2005;161(5):462–471. DOI:10.1093/aje/kwi066.
   PubMed Web of Science ®Google Scholar
• Kuriki K, Wakai K, Hirose K, Matsuo K, Ito H, Suzuki T, Saito T, Kanemitsu Y, Hirai T, Kato T, et al. 2006. Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids. Cancer Epidemiol Biomarkers Prev. 15(10):1791–1798. DOI:10.1158/1055-9965.EPI-06-0180.
   PubMed Web of Science ®Google Scholar
• West NJ, Clark SK, Phillips RK, Hutchinson JM, Leicester RJ, Belluzzi A, Hull MA. Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut. 2010;59(7):918–925. DOI:10.1136/gut.2009.200642.
   PubMed Web of Science ®Google Scholar
• Siezen CL, van Leeuwen AI, Kram NR, Luken ME, van Kranen HJ, Kampman E. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. 2005. Carcinogenesis. 26:449–457. DOI:10.1093/carcin/bgh336.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Kim YH, Cho CH, Kim SH, Lee JE. Circulating levels of vitamin D and colorectal adenoma: a case-control study and a meta-analysis. World J Gastroenterol. 2015;21(29):8868–8877. DOI:10.3748/wjg.v21.i29.8868.
   PubMed Web of Science ®Google Scholar
• Platz EA, Hankinson SE, Hollis BW, Colditz GA, Hunter DJ, Speizer FE, Giovannucci E. 2000. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 9(10):1059–1065.
   PubMed Web of Science ®Google Scholar
• Sadava D, Remer T, Petersen K. 1996. Hyperplasia, hyperproliferation and decreased migration rate of colonic epithelial cells in mice fed a diet deficient in vitamin D. Biol Cell. 87(1–2):113–115.
   PubMed Web of Science ®Google Scholar
• Holt PR, Arber N, Halmos B, Forde K, Kissileff H, McGlynn KA, Moss SF, Kurihara N, Fan K, Yang K, et al. 2002. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol Biomarkers Prev. 11(1):113–119.
   PubMed Web of Science ®Google Scholar
• Deeb KK, Trump DL, Johnson CS. 2007. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 7(9):684–700. DOI:10.1038/nrc2196.
   PubMed Web of Science ®Google Scholar
• Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. 2000. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 60(8):2304–2312.
   PubMed Web of Science ®Google Scholar
• Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, Del Rio M, Barettino D, Volpert O, Muñoz A, Jimenez B. 2005. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene. 24(43):6533–6544. DOI:10.1038/sj.onc.1208801.
   PubMed Web of Science ®Google Scholar
• Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de Herreros AG. 2001. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol. 154(2):369–387.
   PubMed Web of Science ®Google Scholar
• Zheng W, Wong KE, Zhang Z, Dougherty U, Mustafi R, Kong J, Deb DK, Zheng H, Bissonnette M, Li YC. 2012. Inactivation of the vitamin D receptor in APC(min/+) mice reveals a critical role for the vitamin D receptor in intestinal tumor growth. Int J Cancer. 130(1):10–19. DOI:10.1002/ijc.25992.
   PubMed Web of Science ®Google Scholar
• Nagengast FM, Grubben MJ, van Munster IP. 1995. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 31A(7–8):1067–1070.
   PubMed Web of Science ®Google Scholar
• Bayerdörffer E, Mannes GA, Richter WO, Ochsenkühn T, Wiebecke B, Köpcke W, Paumgartner G. 1993. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology. 104(1):145–151.
   PubMed Web of Science ®Google Scholar
• Modica S, Murzilli S, Salvatore L, Schmidt DR, Moschetta A. 2008. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res. 68(23):9589–9594. DOI:10.1158/0008-5472.CAN-08-1791.
   PubMed Web of Science ®Google Scholar
• Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. 1999. Identification of a nuclear receptor for bile acids. Science. 284(5418):1362–1365.
   PubMed Web of Science ®Google Scholar
• Pearson JR, Gill CI, Rowland IR. 2009. Diet, fecal water, and colon cancer–development of a biomarker. Nutr Rev. 67(9):509–526. DOI:10.1111/j.1753-4887.2009.00224.x.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Cai G, Su M, Chen T, Liu Y, Xu Y, Ni Y, Zhao A, Cai S, Xu LX. Urinary metabonomic study on colorectal cancer. J Proteome Res. 2009;9(3):1627–1634. DOI:10.1021/pr901081y.
   Web of Science ®Google Scholar
• Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB. 2008. Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev. 18(1):54–61. DOI:10.1016/j.gde.2008.02.003.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Cheng T. 2010. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 29(3):313–324. DOI:10.1038/onc.2009.358.
   PubMed Web of Science ®Google Scholar
• Sakai T, Yamamoto K, Yokota H, Hakozaki-Usui K, Hino F, Kato I. 1990. Rapid, simple enzymatic assay of free L-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcers. Clin Chem. 36(3):474–476.
   PubMed Web of Science ®Google Scholar
• Patel PS, Adhvaryu SG, Balar DB, Parikh BJ, Shah PM. 1994. Clinical application of serum levels of sialic acid, fucose and seromucoid fraction as tumour markers in human leukemias. Anticancer Res. 14(2B):747–751.
   PubMed Web of Science ®Google Scholar
• Patel PS, Baxi BR, Adhvaryu SG, Balar DB. 1990. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma. Anticancer Res. 10(4):1071–1074.
   PubMed Web of Science ®Google Scholar
• Thompson S, Dargan E, Turner GA. 1992. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett. 66(1):43–48.
   PubMed Web of Science ®Google Scholar
• Ripka J, Adamany A, Stanley P. 1986. Two Chinese hamster ovary glycosylation mutants affected in the conversion of GDP-mannose to GDP-fucose. Arch Biochem Biophys. 249(2):533–545.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang D, Chen KY, Cui M, Wang W, Huang X, Awadellah A, Li Q, Friedman A, Xin WW, et al. 2017. Fucosylation deficiency in mice leads to colitis and adenocarcinoma. Gastroenterology. 152(1):193–205. DOI:10.1053/j.gastro.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Martin D, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25(34):4633–4646. DOI:10.1038/sj.onc.1209597.
   PubMed Web of Science ®Google Scholar
• Pan JG, Mak TW. 2007. Metabolic targeting as an anticancer strategy: dawn of a new era?. Sci STKE. 2007(381):pe14.
   PubMedGoogle Scholar